2026 is a special year for us: APST is celebrating its 15th anniversary. Since our founding, we have stood for…
On December 4, 2025, the ALS app will be presented at the"ALS App Europe Initiative Meeting" at the International Symposium…
Following our last newsletter on the introduction of the OPM classification in the ALS app, we have received numerous queries:…
You can now submit your e-prescription with your health card via the ALS app at your specialist ALS pharmacy! You…
We are pleased to introduce an important new feature in the ALS app today: The new OPM classification is now…
The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis (ALS), in which important findings…
We are pleased to inform you that we have completely revised our medication module. With the new version, we want…
The patient survey on eye control glasses is a nationwide, systematic survey of patients with amyotrophic lateral sclerosis (ALS). The…
The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis (ALS), in which important findings…
The course of ALS (amyotrophic lateral sclerosis) can be very different and individual. The way in which the symptoms develop…